LifeMD semaglutide review
Advertised at $75, billed at $149. Position 0 of 14 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
A programme fee of $149 a month, medication separate, and a business model built on getting your insurer to pay for it.
It is $75 for the first month and $149 after, or nearer $75 on the annual plan. Where coverage lands, patient cost for branded semaglutide can fall to roughly $25 a month.
The numbers
| LifeMD · semaglutide | |
|---|---|
| Advertised | $75/mo |
| Membership | None |
| Billed | $149/mo |
| Advertised-to-billed gap | +$74/mo |
| Per year | $1,788 |
| Board position | 0 of 14, cheapest first |
Same structure. The value depends on whether coverage comes through.
Where the gap is
The $25 figure is real and conditional. It describes an insured patient after approval, and it is doing a lot of work in the marketing.
Against the board
About $1,788 a year in fees at the standard rate, or roughly $900 annual, plus medication where uncovered.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $99 | $149 | +$50 | +$63/mo |
| Ozari Health | $86 | $86 | none | — |
| Trimi | $99 | $99 | none | +$13/mo |
| Zealthy | $151 | $151 | none | +$65/mo |
| Mochi Health | $99 | $178 | +$79 | +$92/mo |
| Hims & Hers | $79 | $188 | +$109 | +$102/mo |
| PlexusDx | $129 | $189 | +$60 | +$103/mo |
| Eden | $99 | $198 | +$99 | +$112/mo |
How the programme works
Physician-led telehealth group with a weight-management programme built around insurance coordination and branded prescriptions.
Verified facts
- GLP-1 injection programme listed at $75 first month, then $149/month.
- Annual plan advertised as low as $75/month.
- Programme fee does not include medication when medication is branded and billed to insurance.
- Markets insurance coordination that can reduce semaglutide cost to roughly $25/month where coverage applies.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- Genuine clinician oversight with a physician-led model.
- Insurance work is a core part of the service, not an afterthought.
- Annual plan meaningfully reduces the programme fee.
Against it
- The programme fee buys care, not medication.
- Cash-pay outcomes are far less attractive than insured ones.
Read this bit. If your insurer declines, the $149/month programme fee still applies and the medication is extra.
Score
3.5 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 3 / 5 |
| Price honesty | 20% | 3.3 / 5 |
| Clinical support | 20% | 4 / 5 |
| Pharmacy sourcing | 15% | 4.2 / 5 |
| Cancelling | 15% | 3.4 / 5 |
Verdict
Excellent with coverage, poor without. Find out which you are before signing.
More from the desk
- Coreage Rx semaglutide review
Advertised at $99, billed at $149. Position 1 of 14 on our board.
- Ozari Health semaglutide review
Advertised at $86 and billed at $86 — no gap. Position 2 of 14 on our board.
- Trimi semaglutide review
Advertised at $99 and billed at $99 — no gap. Position 3 of 14 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.